Literature DB >> 18720629

Association of diabetes mellitus and dyslipidaemias in the Tehran population.

K Ghoddusi1, J Ameli, H Kachuee, V Pourfarziani, A Saadat, Q Karami.   

Abstract

The aim of this survey was to evaluate the role of diabetes in the lipid profiles of the Tehran population. Measurements were carried out on 10 136 people aged 20-69 years for blood sugar, triglycerides, total cholesterol, LDL cholesterol, and HDL cholesterol and data were collected on medical history, physical activity, smoking and obesity. The prevalence of any type of dyslipidaemia in the whole group was 68.5% and of diabetes mellitus was 11.0% (10.6% in men and 11.3% in women). The prevalence of dyslipidaemia in diabetics was 88.9%. There was strong association between diabetes mellitus and dyslipidaemia (P < 0.05). In regression analysis, diabetes was the second most important factor after obesity in secondary dyslipidaemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18720629

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  3 in total

1.  Lipid Profiles and Hepatitis C Viral Markers in HCV-Infected Thalassemic Patients.

Authors:  Seyed-Moayed Alavian; Seyyed Mohammad Miri; Seyed-Vahid Tabatabaei; Maryam Keshvari; Bita Behnava; Pegah Karimi Elizee; Nastaran Mahboobi; Kamran Bagheri Lankarani
Journal:  Gut Liver       Date:  2011-08-18       Impact factor: 4.519

2.  Associations of cardiovascular risk factors in Al Ain, United Arab Emirates.

Authors:  Latifa M Baynouna; Anthony D Revel; Nico J D Nagelkerke; Tariq M Jaber; Aziza O Omar; Nader M Ahmed; Mohammad K Nazirudeen; Mamdouh F Al Sayed; Fuad A Nour; Sameh Abdouni
Journal:  Cardiovasc Diabetol       Date:  2009-04-16       Impact factor: 9.951

Review 3.  Coronary artery disease and its risk factors status in iran: a review.

Authors:  M Ebrahimi; S M R Kazemi-Bajestani; M Ghayour-Mobarhan; G A A Ferns
Journal:  Iran Red Crescent Med J       Date:  2011-09-15       Impact factor: 0.611

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.